138 related articles for article (PubMed ID: 19381801)
1. Mutations in the mitochondrial DNA D-loop region and breast cancer risk.
Ye C; Shu XO; Pierce L; Wen W; Courtney R; Gao YT; Zheng W; Cai Q
Breast Cancer Res Treat; 2010 Jan; 119(2):431-6. PubMed ID: 19381801
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in mtDNA control region of Mizo-Mongloid Breast Cancer samples as revealed by PCR-RFLP analysis.
Ghatak S; Lallawmzuali D; Mukherjee S; Mawia L; Pautu JL; Kumar NS
Mitochondrial DNA A DNA Mapp Seq Anal; 2016 May; 27(3):2205-8. PubMed ID: 25431825
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
4. Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease.
Shen L; Wei J; Chen T; He J; Qu J; He X; Jiang L; Qu Y; Fang H; Chen G; Lu J; Bai Y
J Cancer Res Clin Oncol; 2011 Apr; 137(4):669-75. PubMed ID: 20552226
[TBL] [Abstract][Full Text] [Related]
5. Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women.
Ye C; Gao YT; Wen W; Breyer JP; Shu XO; Smith JR; Zheng W; Cai Q
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2117-22. PubMed ID: 18708405
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases.
Ye C; Shu XO; Wen W; Pierce L; Courtney R; Gao YT; Zheng W; Cai Q
Breast Cancer Res Treat; 2008 Apr; 108(3):427-34. PubMed ID: 17541740
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial genotype and breast cancer predisposition.
Czarnecka AM; Krawczyk T; Plak K; Klemba A; Zdrozny M; Arnold RS; Kofler B; Golik P; Szybinska A; Lubinski J; Mossakowska M; Bartnik E; Petros JA
Oncol Rep; 2010 Dec; 24(6):1521-34. PubMed ID: 21042748
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial D310 instability in Asian Indian breast cancer patients.
Alhomidi MA; Vedicherla B; Movva S; Rao PK; Ahuja YR; Hasan Q
Tumour Biol; 2013 Aug; 34(4):2427-32. PubMed ID: 23640059
[TBL] [Abstract][Full Text] [Related]
9. Mutations of mitochondrial DNA as potential biomarkers in breast cancer.
Cai FF; Kohler C; Zhang B; Chen WJ; Barekati Z; Garritsen HS; Lenner P; Toniolo P; Zhang JJ; Zhong XY
Anticancer Res; 2011 Dec; 31(12):4267-71. PubMed ID: 22199290
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population.
Jiang H; Zhao H; Xu H; Hu L; Wang W; Wei Y; Wang Y; Peng X; Zhou F
Cancer Sci; 2014 Jun; 105(6):639-45. PubMed ID: 24703408
[TBL] [Abstract][Full Text] [Related]
11. Nuclear and mitochondrial genome instability in human breast cancer.
Richard SM; Bailliet G; Páez GL; Bianchi MS; Peltomäki P; Bianchi NO
Cancer Res; 2000 Aug; 60(15):4231-7. PubMed ID: 10945635
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer.
Tseng LM; Yin PH; Chi CW; Hsu CY; Wu CW; Lee LM; Wei YH; Lee HC
Genes Chromosomes Cancer; 2006 Jul; 45(7):629-38. PubMed ID: 16568452
[TBL] [Abstract][Full Text] [Related]
13. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
[TBL] [Abstract][Full Text] [Related]
14. Correlational study on mitochondrial DNA mutations as potential risk factors in breast cancer.
Li L; Chen L; Li J; Zhang W; Liao Y; Chen J; Sun Z
Oncotarget; 2016 May; 7(21):31270-83. PubMed ID: 27121313
[TBL] [Abstract][Full Text] [Related]
15. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the mitochondrial genome in human breast cancers.
Tseng LM; Yin PH; Yang CW; Tsai YF; Hsu CY; Chi CW; Lee HC
Genes Chromosomes Cancer; 2011 Oct; 50(10):800-11. PubMed ID: 21748819
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer.
Tang D; Cho S; Rundle A; Chen S; Phillips D; Zhou J; Hsu Y; Schnabel F; Estabrook A; Perera FP
Breast Cancer Res Treat; 2002 Sep; 75(2):159-66. PubMed ID: 12243508
[TBL] [Abstract][Full Text] [Related]
18. An A10398G mitochondrial DNA alteration is related to increased risk of breast cancer, and associates with Her2 positive receptor.
Jahani MM; Azimi Meibody A; Karimi T; Banoei MM; Houshmand M
Mitochondrial DNA A DNA Mapp Seq Anal; 2020 Jan; 31(1):11-16. PubMed ID: 31797714
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial control region alterations and breast cancer risk: a study in South Indian population.
Tipirisetti NR; Govatati S; Pullari P; Malempati S; Thupurani MK; Perugu S; Guruvaiah P; Rao K L; Digumarti RR; Nallanchakravarthula V; Bhanoori M; Satti V
PLoS One; 2014; 9(1):e85363. PubMed ID: 24497926
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Tan DJ; Bai RK; Wong LJ
Cancer Res; 2002 Feb; 62(4):972-6. PubMed ID: 11861366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
